{
  "CitationSubset": [],
  "KeywordList": [
    [
      "Cancer",
      "Cell culture",
      "Organoids"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33870230",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "31"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "100429",
      "10.1016/j.xpro.2021.100429"
    ],
    "Journal": {
      "ISSN": "2666-1667",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "2",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "18"
        }
      },
      "Title": "STAR protocols",
      "ISOAbbreviation": "STAR Protoc"
    },
    "ArticleTitle": "Protocol for establishing organoids from human ovarian cancer biopsies.",
    "Pagination": {
      "StartPage": "100429",
      "MedlinePgn": "100429"
    },
    "Abstract": {
      "AbstractText": [
        "Ovarian cancer (OC) is the most lethal gynecological cancer. Faithful research models are indispensable to the progression of understanding OC etiology and therapy. Here, we provide a detailed protocol for establishing organoid cultures from patient OC biopsies. The organoids reproduce primary tumor- and patient-specific characteristics including phenotypic properties and genomic aberrations and exhibit patient-dependent responsiveness to drugs. OC-derived organoids provide powerful tools to gain deep insight into the cancer's pathobiology and to screen patient-tumor drug sensitivity to progress toward personalized medicine. For complete details on the use and execution of this protocol, please refer to Maenhoudt et\u00a0al. (2020)."
      ],
      "CopyrightInformation": "\u00a9 2021 The Authors."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven (University of Leuven), Leuven, Belgium."
          }
        ],
        "LastName": "Maenhoudt",
        "ForeName": "Nina",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven (University of Leuven), Leuven, Belgium."
          }
        ],
        "LastName": "Vankelecom",
        "ForeName": "Hugo",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "STAR Protoc",
    "NlmUniqueID": "101769501",
    "ISSNLinking": "2666-1667"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Biopsy"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Cell Culture Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "cytology"
      ],
      "DescriptorName": "Organoids"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Precision Medicine"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}